Alembic Pharmaceuticals has received USFDA approval for its Telmisartan and Amlodipine tablets in the strengths of 40mg/5 mg, 40mg/10 mg, 80mg/5 mg and 80mg/10 mg, used for treatment of hypertension. The company’s product is generic version of Boehringer Ingelheim Pharmaceuticals Inc’s Twynsta tablets in the same strengths. The company now has a total of 50 abbreviated new drug application (ANDA) approvals (44 final approvals and six tentative approvals) from the USFDA.
Company Profile : Alembic Pharmaceuticals Ltd
Leave a Reply